Chitosan–EDTA New Combination is a Promising Candidate for Treatment of Bacterial and Fungal Infections
- 21 October 2010
- journal article
- research article
- Published by Springer Nature in Current Microbiology
- Vol. 62 (3) , 739-745
Abstract
Chitosan is an attractive preparation widely used as a pharmaceutical excipient. This study aimed to evaluate the antimicrobial activities of chitosan derivatives, EDTA, and the newly developed chitosan–EDTA combination against Gram-negative and Gram-positive bacteria as well as Candida albicans. Antimicrobial activity was studied. Both minimal Inhibitory Concentrations (MIC) and minimal biocidal concentrations (MBC) were determined. Chitosan acetic acid recorded lower MIC values against Enterococcus faecalis, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans than those exhibited by EDTA. EDTA failed to have inhibitory activity against Enterococcus faecalis as well as MBC against any of the studied microorganisms. Chitosan acetic acid’s MBC were recorded to all examined species. Checkerboard assay results indicated a synergistic antimicrobial activity of the new combination against Staphylococcus aureus and an additive effect against other microorganisms. Moreover, a short microbial exposure to chitosan–EDTA (20–30 min) caused complete eradication. Due to the continuous emergence of resistant strains, there is an urgent need to discover new antimicrobial agents. Our findings suggest the use of chitosan as an enhancing agent with antibacterial and antifungal properties in combination with EDTA in pharmaceutical preparations.Keywords
This publication has 30 references indexed in Scilit:
- The assessment of the antibacterial and antifungal activities of aspirin, EDTA and aspirin-EDTA combination and their effectiveness as antibiofilm agentsJournal of Applied Microbiology, 2009
- Species distribution and antimicrobial susceptibility of gram-negative aerobic bacteria in hospitalized cancer patientsJournal of Translational Medicine, 2009
- Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patientsJournal of Translational Medicine, 2009
- Insights into the Mode of Action of Chitosan as an Antibacterial CompoundApplied and Environmental Microbiology, 2008
- In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureussevere respiratory infectionsBMC Infectious Diseases, 2007
- A subpopulation ofCandida albicansandCandida tropicalisbiofilm cells are highly tolerant to chelating agentsFEMS Microbiology Letters, 2007
- Optimal Antimicrobial Catheter Lock Solution, Using Different Combinations of Minocycline, EDTA, and 25-Percent Ethanol, Rapidly Eradicates Organisms Embedded in BiofilmAntimicrobial Agents and Chemotherapy, 2007
- In vitro evaluation of chitosan-EDTA conjugate polyplexes as a nanoparticulate gene delivery systemThe AAPS Journal, 2006
- Comparative In Vitro Efficacies of Various Catheter Lock SolutionsAntimicrobial Agents and Chemotherapy, 2006
- Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studiesJournal of Controlled Release, 2004